Trials / Completed
CompletedNCT01524796
NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark
NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions In Denmark
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 128 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational study to assess the effectiveness and use of pregabalin (Lyrica) in the treatment of patients with peripheral neuropathic pain in real-life daily clinical practice.
Detailed description
General practitioners and specialists participate in the study. When a subject, independently of the study and before consideration for observation in the study has been prescribed pregabalin for treatment of peripheral NeP, the subject can (before first dose of pregabalin is taken) be included in the observational program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention. Non-interventional study | No intervention. Non-interventional study |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2012-02-02
- Last updated
- 2021-01-28
- Results posted
- 2015-03-31
Source: ClinicalTrials.gov record NCT01524796. Inclusion in this directory is not an endorsement.